The Harvard Medical School ABMG (American Board of Medical Genetics) fellowship in Clinical Cytogenetics requires participation by trainees for a minimum of 24 months.
One year of the fellowship is dedicated primarily to work in the clinical laboratory. During this period, the fellow participates in rotations that provide experience with all types of specimens processed in the BWH Laboratory. Fellows also are expected to participate in a variety of didactic sessions and seminars and play an active role in new assay validation, as well as assume responsibility for carrying a clinical pager.
Harvard Medical School is accredited by the American Board of Medical Genetics to provide training in Clinical Cytogenetics. The overall goals of the cytogenetics training program are to:
Teach the principles of cytogenetics as applied to diagnostic testing
Expose fellows to major techniques used in clinical cytogenetics
Provide experience in both conventional cytogenetic and cutting-edge molecular cytogenomic techniques, including both constitutional and cancer microarray testing
Teach the major clinical indications for cytogenetic testing and the clinical implications of test results (samples types include peripheral bloods, fibroblasts, amniotic fluids, chorionic villi, hematology-oncology specimens, and solid tumors)
Allow fellows to become familiar with constitutional cytogenetic syndromes, principles of prenatal cytogenetic diagnosis, and cancer cytogenetics
Help fellows develop communication skills necessary for interaction with other healthcare professionals as well as patients
Convey an appreciation of issues in quality assurance necessary to management of a diagnostic laboratory
Convey a range of ethical issues involved in the practice of clinical cytogenetics